Early-stage triple-negative breast cancer is unlikely to be cured
Triple-negative breast cancer is a malignant tumor, and the effect of targeted therapy and endocrine therapy is not obvious, so the prognosis is relatively poor, although it is early, there is a risk of recurrence and metastasis after surgery, and it is difficult to be completely cured.
However, if early triple-negative breast cancer patients can actively cooperate with doctors to take surgical treatment, some patients can also undergo radical surgical resection and axillary lymph node dissection after surgery, which can prolong the patients’ life expectancy generally up to 5-10 years, and there are patients who will survive for a longer period of time.
Once diagnosed with early-stage triple-negative breast cancer, patients should actively cooperate with their doctors to take treatment and undergo regular review.